KARACHI, Pakistan 

Pakistani scientists are awaiting approval to start clinical trials for a treatment they claim can cure coronavirus.

A research team from Dow University of Medical Sciences, the country’s leading health institution, has devised intravenous immunoglobulin (IVIG) with plasma obtained from the blood of patients recovered from coronavirus, according to a statement.

The plasma teeming with anti-bodies was donated by patients after recovering from the illness.

Lab tests and animal trials were successful. The next step is to initiate clinical trials.

“This is a very important breakthrough in the war against COVID-19,” professor Shaukat Ali, the head of the

Read more: Pakistan awaits clinical trials for COVID-19 treatment